Scivono

Vonoprazan

THERAPEUTIC SEGMENT:
Gastroenterology

INDICATIONS:
Scivono (Vonoprazan) is indicated for:

  1. Gastric ulcer, duodenal ulcer, reflux esophagitis, prevention of recurrence of gastric or duodenal ulcer during low-dose aspirin administration, prevention of recurrence of gastric or duodenal ulcer during non-steroidal anti-inflammatory drug (NSAID) administration.
  2. Adjunct to Helicobacter pylori eradication in the following settings: Gastric ulcer, duodenal ulcer, gastric mucosa-associated lymphatic tissue (MALT) lymphoma, idiopathic thrombocytopenic purpura, the stomach after endoscopic resection of early stage gastric cancer or Helicobacter pylori gastritis.

BRIEF DESCRIPTION:
Vonoprazan is a potassium competitive acid blocker (P-CAB) and does not require activation by acid. It inhibits H+, K+-ATPase in a reversible and potassium-competitive manner. Vonoprazan has a strong basicity and resides on the acid production site of gastric parietal cells for a long time, thereby inhibiting gastric acid production.

DOSAGE FORM:
Tablets
10mg and
20mg

Disclaimer: For use under medical prescription only

Reviews

There are no reviews yet.

Be the first to review “Vonoprazan”

Your email address will not be published. Required fields are marked *